Brief: Redcare Pharmacy Q3 Sales EUR 847 Million
BRIEF-Redcare Pharmacy Q3 Sales EUR 847 Million Oct 29 (Reuters) - Redcare Pharmacy NV RDC.DE:
Q3 SALES EUR 847 MILLION
Q3 NET INCOME EUR 1 MILLION
Q3 ADJUSTED EBITDA UP 68% YOY TO EUR 28.70 MILLION; MARGIN 3.4%
Q3 RX REVENUE UP 31% YOY; RX GERMANY UP 56% YOY
CONFIRMS FY2026 GUIDANCE: REVENUE GROWTH 16%-18%, RX GERMANY EUR 730-760 MILLION, ADJUSTED EBITDA MARGIN 2.5%-3.0%
Q3 DACH ADJUSTED EBITDA EUR 29 MILLION, MARGIN 4.2%, UP FROM 3.0%
Q3 NET INCOME POSITIVE AT EUR 1 MILLION; FREE CASH FLOW EUR 15 MILLION
Q3 GROUP REVENUE UP 18% YOY TO EUR 847 MILLION; 9M REVENUE EUR 2.55 BILLION, UP 19%
Further company coverage: RDC.DE
(Gdansk Newsroom)
((Reuters Messaging: Gdansk.newsroom@thomsonreuters.com ; +48 58 7696600))
Recent news on Redcare Pharmacy NV
See all newsNetherlands' Redcare Pharmacy slightly beats Q3 revenue estimates on strong prescription sales in Germany
Brief: Redcare Pharmacy Q3 Sales EUR 847 Million
Brief: Redcare Pharmacy Appoints Peter Schmid Von Linstow As CEO
Europe Research Roundup: DEUTZ, Legrand, VAT
Brief: Redcare Pharmacy Now Expects FY Total Revenue Growth of 16% to 18%